We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Cognito Therapeutics’ gamma sensory stimulation therapy reduced white matter atrophy in the brains of patients with Alzheimer’s disease in a six-month study, the company announced at the Alzheimer’s Association International Conference 2022 in San Diego. Read More
Janet Woodcock, principal deputy FDA commissioner, made clear the dire situation her agency will be in if user fees aren’t rapidly reauthorized and the FDA doesn’t receive new money from Congress to update its flagging IT infrastructure. Read More